Abstract:Systemic sclerosis (SSc) is a chronic multisystemic disease characterized by immunological activation, diffuse vasculopathy, and generalized fibrosis exhibiting a variety of symptoms. A recognized precursor of SSc is Raynaud's phenomenon, which is part of the very early disease of systemic sclerosis (VEDOSS) in combination with nailfold videocapillaroscopy (NVC) impairment. The pathophysiology of ocular involvement, alterations in internal organs, and body integumentary system involvement in SSc patients are complicated and poorly understood, with multiple mechanisms presumptively working together. The most prevalent ocular symptoms of SSc are abnormalities of the eyelids and conjunctiva as well as dry eye syndrome, due to fibroblasts' dysfunction and inflammation of the ocular surface. In particular, lagophthalmos, blepharophimosis limitation of eyelid motion, eyelid telangiectasia, and rigidity or tightening of the lids may affect up to two-third of the patients. In addition, reduction in central corneal thickness, iris defects and higher rates of glaucoma were reported. In the first reports based on retinography or fluorescein angiography, about 50% of SSc patients showed signs of vascular disease: peripheral artery occlusion, thinning of retinal pigment epithelium and choroidal capillaries, ischemic areas surrounded by intraretinal extravasation and microaneurysms, and peripheral capillary non-perfusion. Successively, thanks to the advent of optical coherence tomography angiography (OCTA), several studies highlighted significant impairment of either the choriocapillaris and retinal vascular plexuses, also correlating with NVC involvement and skin disease, even in VEDOSS disease. Given the sensitivity of this technique, ocular micro-vasculopathy may act as a tool for early SSc identification and discriminate between disease stages.

What problem does this paper attempt to address?

The paper aims to review and analyze the latest scientific research on patients with systemic sclerosis (SSc) and explore the relationship between their ocular symptoms and the stages of the disease. Specifically, the paper focuses on new insights into microvascular damage, utilizing new technologies such as optical coherence tomography angiography (OCTA) for research. ### Issues the Paper Attempts to Address: 1. **Ocular Symptoms and Their Relationship with Disease Stages**: - Patients with systemic sclerosis exhibit various ocular symptoms, including eyelid abnormalities, dry eye syndrome, conjunctivitis, etc. - How are these symptoms associated with the early or late stages of the disease? 2. **New Insights into Microvascular Damage**: - Using OCTA technology, researchers can observe microvascular changes in greater detail. - How are these changes related to other symptoms of systemic sclerosis? 3. **Early Diagnostic Tools**: - Research has found that OCTA can be used as a tool for early identification of systemic sclerosis. - Can this technology be used to distinguish between different stages of the disease? Through these studies, the paper hopes to better understand the ocular manifestations of systemic sclerosis and its pathological mechanisms, thereby providing new ideas and technical support for clinical diagnosis and treatment.

Ocular Involvement in Systemic Sclerosis: Updated Review and New Insights on Microvascular Impairment